Inventor
CHAPARRO RODOLFO J
US30 patents
⚠️ This page may combine multiple inventors who share the name “CHAPARRO RODOLFO J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CUE BIOPHARMA INC
29 patentsUS11377478B2Jul 5, 2022
T-cell modulatory multimeric polypeptides and methods of use thereof
CUE BIOPHARMA INC25 citations98
US11370821B2Jun 28, 2022
T-cell modulatory multimeric polypeptides and methods of use thereof
CUE BIOPHARMA INC20 citations98
US11117945B2Sep 14, 2021
T-cell modulatory multimeric polypeptides and methods of use thereof
CUE BIOPHARMA INC28 citations98
US10927161B2Feb 23, 2021
Methods for modulating an immune response
CUE BIOPHARMA INC33 citations98
US11851467B2Dec 26, 2023
T-cell modulatory multimeric polypeptides and methods of use thereof
CUE BIOPHARMA INC9 citations94
US11767355B2Sep 26, 2023
Methods for modulating an immune response
CUE BIOPHARMA INC13 citations94
US11739133B2Aug 29, 2023
T-cell modulatory multimeric polypeptides and methods of use thereof
CUE BIOPHARMA INC12 citations94
US11708400B2Jul 25, 2023
T-cell modulatory multimeric polypeptides and methods of use thereof
CUE BIOPHARMA INC15 citations94
US11530248B2Dec 20, 2022
T-cell modulatory multimeric polypeptides and methods of use thereof
CUE BIOPHARMA INC14 citations94
US11505588B2Nov 22, 2022
T-cell modulatory multimeric polypeptides and methods of use thereof
CUE BIOPHARMA INC15 citations94
US11479595B2Oct 25, 2022
Methods for modulating an immune response
CUE BIOPHARMA INC19 citations94
US11104712B2Aug 31, 2021
Methods for modulating an immune response
CUE BIOPHARMA INC19 citations94
US11905320B2Feb 20, 2024
T-cell modulatory multimeric polypeptides and methods of use thereof
CUE BIOPHARMA INC5 citations86
US11702461B2Jul 18, 2023
T-cell modulatory multimeric polypeptides comprising reduced-affinity immunomodulatory polypeptides
CUE BIOPHARMA INC9 citations86
US11878062B2Jan 23, 2024
Multimeric T-cell modulatory polypeptides and methods of use thereof
CUE BIOPHARMA INC9 citations83
US12006348B2Jun 11, 2024
T-cell modulatory multimeric polypeptide with conjugation sites and methods of use thereof
CUE BIOPHARMA INC3 citations74
US12421287B2Sep 23, 2025
T-cell modulatory multimeric polypeptides and methods of use thereof
CUE BIOPHARMA INC0 citations73
US12180258B2Dec 31, 2024
T-cell modulatory multimeric polypeptides and methods of use thereof
CUE BIOPHARMA INC1 citations73
US12152061B2Nov 26, 2024
T-cell modulatory multimeric polypeptides and methods of use thereof
CUE BIOPHARMA INC1 citations73
US12145973B2Nov 19, 2024
T-cell modulatory multimeric polypeptides and methods of use thereof
CUE BIOPHARMA INC1 citations73
US11987610B2May 21, 2024
T-cell modulatory multimeric polypeptides and methods of use thereof
CUE BIOPHARMA INC1 citations73
US11958893B2Apr 16, 2024
Methods for modulating an immune response
CUE BIOPHARMA INC1 citations73
US11692018B2Jul 4, 2023
TGF-β polypeptides
CUE BIOPHARMA INC2 citations72
US12528850B2Jan 20, 2026
TGF-β polypeptides
CUE BIOPHARMA INC0 citations62
US12029782B2Jul 9, 2024
MHC class II T-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (T1D) and methods of use thereof
CUE BIOPHARMA INC1 citations62
US11993641B2May 28, 2024
Methods for modulating an immune response
CUE BIOPHARMA INC0 citations62
US12485183B2Dec 2, 2025
Multimeric T-cell modulatory polypeptides and methods of use thereof
CUE BIOPHARMA INC0 citations60
US12485184B2Dec 2, 2025
Multimeric T-cell modulatory polypeptides and methods of use thereof
CUE BIOPHARMA INC0 citations60
US12257311B2Mar 25, 2025
Multimeric T-cell modulatory polypeptides and methods of use thereof
CUE BIOPHARMA INC0 citations60